Literature DB >> 11861499

Impairment of liver GH receptor signaling by fasting.

Váronique Beauloye1, Bertrand Willems, Virginie de Coninck, Stuart J Frank, Marc Edery, Jean-Paul Thissen.   

Abstract

Fasting causes a state of GH resistance responsible for low circulating IGF-I levels. To investigate whether this resistance may result from alterations in the GH signaling pathway, we determined the effects of fasting on the GH transduction pathway in rat liver. Forty-eight-hour fasted or fed male rats were injected with recombinant rat GH via the portal vein. Liver was removed 0 and 15 min after injection. Although GH stimulated Janus kinase 2 (JAK2) phosphorylation in all animals, this was severely blunted in fasted animals. Similarly, the phosphorylation of the GH receptor, although observed in both fasted and fed rats after GH injection, was markedly reduced in fasted rats. A rapid signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation was also induced in the liver of fed animals in response to GH. In contrast, in fasted rats only a slight phosphorylated STAT5 signal was observed. The inhibitory effect of fasting on these GH signaling molecules occurred without changes in their protein content. Furthermore, the impairment of the JAK-STAT pathway in fasted animals was associated with increased liver suppressor of cytokine signaling 3 mRNA levels. Although glucocorticoids, which are increased by fasting, may cause GH resistance, adrenalectomy failed to prevent alterations in the JAK-STAT pathway caused by fasting. In conclusion, the GH resistance induced by fasting is associated with impairment of the JAK-STAT signaling pathway. This might contribute to the decrease in liver IGF-I production observed in fasting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861499     DOI: 10.1210/endo.143.3.8692

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Authors:  Peter Rotwein
Journal:  Trends Endocrinol Metab       Date:  2012-02-21       Impact factor: 12.015

2.  Hepatic growth hormone resistance after acute injury.

Authors:  Ryan M Corrick; Li Li; Stuart J Frank; Joseph L Messina
Journal:  Endocrinology       Date:  2013-02-15       Impact factor: 4.736

Review 3.  Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Authors:  Raul M Luque; Manuel D Gahete; Jose Cordoba-Chacon; Gwen V Childs; Rhonda D Kineman
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

4.  Effects of Short-term Fasting on Ghrelin/GH/IGF-1 Axis in Healthy Humans: The Role of Ghrelin in the Thrifty Phenotype.

Authors:  Tim Hollstein; Alessio Basolo; Yigit Unlu; Takafumi Ando; Mary Walter; Jonathan Krakoff; Paolo Piaggi
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

5.  LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.

Authors:  Thierry Touvier; Françoise Conte-Auriol; Olivier Briand; Céline Cudejko; Réjane Paumelle; Sandrine Caron; Eric Baugé; Yves Rouillé; Jean-Pierre Salles; Bart Staels; Bernard Bailleul
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

6.  Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.

Authors:  Feng Gu; Nadia Dubé; Jin Wook Kim; Alan Cheng; Maria de Jesus Ibarra-Sanchez; Michel L Tremblay; Yves R Boisclair
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

7.  SIRT1 regulates adaptive response of the growth hormone--insulin-like growth factor-I axis under fasting conditions in liver.

Authors:  Masaaki Yamamoto; Genzo Iguchi; Hidenori Fukuoka; Kentaro Suda; Hironori Bando; Michiko Takahashi; Hitoshi Nishizawa; Susumu Seino; Yutaka Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

8.  Intracellular signaling transduction pathways triggered by a well-known anti-GHR monoclonal antibody, Mab263, in vitro and in vivo.

Authors:  Hainan Lan; Wei Li; Hailong Jiang; Yanhong Yang; Xin Zheng
Journal:  Int J Mol Sci       Date:  2014-11-10       Impact factor: 5.923

Review 9.  Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.

Authors:  Christoffer Soendergaard; Jonathan A Young; John J Kopchick
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

10.  Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.

Authors:  Takeshi Inagaki; Vicky Y Lin; Regina Goetz; Moosa Mohammadi; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.